| Primary |
| Pulmonary Arterial Hypertension |
40.4% |
| Pulmonary Hypertension |
19.0% |
| Product Used For Unknown Indication |
11.7% |
| Prophylaxis |
4.6% |
| Hypertension |
4.3% |
| Idiopathic Pulmonary Fibrosis |
2.7% |
| Oedema |
2.1% |
| Drug Use For Unknown Indication |
1.9% |
| Supplementation Therapy |
1.6% |
| Atrial Fibrillation |
1.2% |
| Right Ventricular Failure |
1.2% |
| Cardiac Failure |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Asthma |
1.1% |
| Scleroderma |
1.0% |
| Coronary Artery Disease |
0.9% |
| Hypothyroidism |
0.9% |
| Pain |
0.9% |
| Hypercholesterolaemia |
0.9% |
|
| Death |
19.5% |
| Right Ventricular Failure |
13.1% |
| Cardiac Failure |
6.7% |
| Oedema Peripheral |
5.4% |
| Pulmonary Hypertension |
5.4% |
| Weight Increased |
4.2% |
| Liver Function Test Abnormal |
3.9% |
| Pneumonia |
3.9% |
| Respiratory Failure |
3.9% |
| Haemoptysis |
3.7% |
| Hepatic Enzyme Increased |
3.7% |
| Interstitial Lung Disease |
3.2% |
| Pulmonary Oedema |
3.2% |
| Transaminases Increased |
3.2% |
| Pleural Effusion |
3.0% |
| Pregnancy |
3.0% |
| Pulmonary Arterial Hypertension |
3.0% |
| Hepatitis |
2.7% |
| Hypoxia |
2.7% |
| Oedema |
2.7% |
|
| Secondary |
| Pulmonary Arterial Hypertension |
36.3% |
| Pulmonary Hypertension |
18.4% |
| Product Used For Unknown Indication |
15.9% |
| Drug Use For Unknown Indication |
5.2% |
| Idiopathic Pulmonary Fibrosis |
3.2% |
| Hypertension |
2.7% |
| Prophylaxis |
2.2% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Cardiac Failure |
1.7% |
| Anaemia |
1.3% |
| Collagen Disorder |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Gastritis Prophylaxis |
1.2% |
| Scleroderma |
1.2% |
| Atrial Fibrillation |
1.1% |
| Medical Diet |
1.1% |
| Pain |
1.1% |
| Hyperuricaemia |
0.9% |
| Psoriasis |
0.9% |
| Thrombosis Prophylaxis |
0.9% |
|
| Liver Disorder |
9.9% |
| Dizziness |
8.7% |
| Death |
7.6% |
| Right Ventricular Failure |
7.6% |
| Liver Function Test Abnormal |
5.8% |
| Syncope |
5.8% |
| Cardiac Failure |
5.2% |
| Pulmonary Arterial Hypertension |
5.2% |
| Dyspnoea |
4.7% |
| Tremor |
4.7% |
| Flushing |
4.1% |
| Haemoptysis |
4.1% |
| Idiopathic Pulmonary Fibrosis |
4.1% |
| Hepatic Enzyme Increased |
3.5% |
| Nasal Congestion |
3.5% |
| Pulmonary Hypertension |
3.5% |
| Urinary Tract Infection |
3.5% |
| Gamma-glutamyltransferase Increased |
2.9% |
| Hypoxia |
2.9% |
| Oedema |
2.9% |
|
| Concomitant |
| Pulmonary Arterial Hypertension |
38.9% |
| Pulmonary Hypertension |
24.9% |
| Product Used For Unknown Indication |
5.0% |
| Prophylaxis |
4.0% |
| Raynaud's Disease |
3.0% |
| Scleroderma |
3.0% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Hiv Infection |
2.7% |
| Chills |
2.0% |
| Osteoporosis |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Diuretic Therapy |
1.3% |
| Hypertension |
1.3% |
| Interstitial Lung Disease |
1.3% |
| Primary Pulmonary Hypertension |
1.3% |
| Systemic Lupus Erythematosus |
1.3% |
| Anticoagulant Therapy |
1.0% |
| Bronchitis |
1.0% |
| Cardiac Disorder Prophylaxis |
1.0% |
| Cor Pulmonale Chronic |
1.0% |
|
| Death |
25.4% |
| Off Label Use |
7.5% |
| Vision Blurred |
6.0% |
| Hepatic Pain |
4.5% |
| Pulmonary Hypertension |
4.5% |
| Right Ventricular Failure |
4.5% |
| Syncope |
4.5% |
| Tachycardia |
4.5% |
| Ventricular Tachycardia |
4.5% |
| Visual Impairment |
4.5% |
| Abdominal Hernia |
3.0% |
| Cardiomegaly |
3.0% |
| General Physical Health Deterioration |
3.0% |
| Hepatic Failure |
3.0% |
| Hepatosplenomegaly |
3.0% |
| Hypokalaemia |
3.0% |
| Lower Respiratory Tract Infection |
3.0% |
| Malaise |
3.0% |
| Musculoskeletal Pain |
3.0% |
| Nausea |
3.0% |
|
